Garry E. Menzel is President at TCR2 THERAPEUTICS INC. (TCRR). They have made 1 open-market trade across 1 company since 2022, most recently 2023-07-10.
CIK 0001556064
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADAP | SELL | 2023-07-10 | 2023-07-10 | $0.91 | $43K | +0.2% | -8.9% | -26.5% |
| TCRR | SELL · 10b5-1 | 2022-12-09 | 2022-12-13 | $1.10 | $35K | -15.1% | +31.0% | +43.0% |
| TCRR | SELL · 10b5-1 | 2022-12-07 | 2022-12-09 | $1.26 | $23K | -25.0% | +2.6% | +34.5% |
| TCRR | SELL · 10b5-1 | 2022-12-05 | 2022-12-07 | $1.36 | $32K | -31.3% | -6.3% | +25.0% |
| TCRR | SELL · 10b5-1 | 2022-12-02 | 2022-12-05 | $1.39 | $12K | -29.7% | -23.9% | +17.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.